Evidence map›Paper›PMID 34624169›Full record

ArticleAngewandte Chemie (International ed. in English)2021

DNA Tiling Enables Precise Acylation-Based Labeling and Control of mRNA.

Lu Xiao, Yong Woong Jun, Eric T Kool

Open access · greenAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Nitro Reduction-Based RNA Control and Ultrafast Release.Angewandte Chemie (International ed. in English) · 2026
    Article
  2. Article
  3. Sequence-Specific Installation of Aryl Groups in RNA via DNA-Catalyst Conjugates.Angewandte Chemie (International ed. in English) · 2025
    Article
  4. Localized 2'-OH Acylation at Poly(A) Extends RNA Translation.Journal of the American Chemical Society · 2025
    Article
  5. Article
  6. Site-Selective Modification and Labeling of Native RNA.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Conjugation of RNAChemical communications (Cambridge, England) · 2022
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lu XiaoDepartment of Chemistry, Stanford University, Stanford, CA, 94305, USA.ORCID 0000-0003-1934-4711
Yong Woong JunDepartment of Chemistry, Stanford University, Stanford, CA, 94305, USA.ORCID 0000-0001-9359-1265
Eric T KoolDepartment of Chemistry, Stanford University, Stanford, CA, 94305, USA.ORCID 0000-0002-7310-2935
Stanford University · US

Funding

Covalent Profiling of RNA Targets and Off-targetsR01GM130704 · NIGMS · STANFORD UNIVERSITY · PI KOOL, ERIC T. · 2019 to 2022
$1.5M
Probing the Transcriptome with Multifunctional Acylation ChemistryR01GM127295 · NIGMS · STANFORD UNIVERSITY · PI KOOL, ERIC T. · 2018 to 2021
$1.3M
Foundation for the National Institutes of Health GM127295Foundation for the National Institutes of Health GM130704NIGMS NIH HHS R01 GM127295NIGMS NIH HHS R01 GM130704
6 · The paper itself

Abstract

Methods for the site-selective labeling of long, native RNAs are needed for studying mRNA biology and future therapies. Current approaches involve engineering RNA sequences, which may alter folding, or are limited to specific sequences or bases. Here, we describe a versatile strategy for mRNA conjugation via a novel DNA-tiling approach. The method, TRAIL, exploits a pool of "protector" oligodeoxynucleotides to hybridize and block the mRNA, combined with an "inducer" DNA that extrudes a reactive RNA loop for acylation at a predetermined site. Using TRAIL, an azido-acylimidazole reagent was employed for labeling and controlling RNA for multiple applications in vitro and in cells, including analysis of RNA-binding proteins, imaging mRNA in cells, and analysis and control of translation. The TRAIL approach offers an efficient and accessible way to label and manipulate RNAs of virtually any length or origin without altering native sequence.

Indexed as

AcylationDNARNA, MessengerDNARNA, MessengeracylationDNA tilingmRNAsite-selective labelingtranslation switching

Identifiers

PMID34624169
PMCPMC8649056
OpenAlexW3203573136

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.